Sorafenib Stada

Sorafenib Stada is an oral medication used for certain types of cancer treatment. It belongs to the kinase inhibitor class and is prescribed to help manage advanced kidney or liver cancer. This product is manufactured by Stada Arzneimittel Ag and is available for oral use.

Sorafenib Stada is prescribed to treat advanced renal cell carcinoma, a type of kidney cancer, and hepatocellular carcinoma, a type of liver cancer. It works by slowing the growth of cancer cells. Patients often ask, what is Sorafenib used for, and this medication is specifically indicated for these cancer types under medical supervision.

Common effects of Sorafenib Stada may include fatigue, rash, or diarrhea. Some patients experience hand-foot skin reactions or high blood pressure. These effects vary by individual and should be monitored by a healthcare provider.

Sorafenib Stada should be taken exactly as prescribed by a healthcare professional. It is important to discuss your full medical history, including liver or heart conditions, with your doctor before starting this medication. Regular monitoring may be required during treatment.

Sorafenib Stada may interact with certain medications, including strong CYP3A4 inhibitors or inducers, such as ketoconazole or rifampin. Grapefruit products and alcohol may also affect how this medication works. Always inform your healthcare provider about all medications and supplements you are taking.